Press release
Biopsy is defined as a procedure of removing or extracting tissue from the body through various methods, such as surgical, needle, laparoscopic techniques.
The global virtual biopsy market, valued at USD 0.73 billion in 2024, is projected to reach USD 0.78 billion in 2025 and USD 3.02 billion by 2035, representing a CAGR of 14.47% during the forecast period.This procedure plays a crucial role in the diagnosis or monitoring of certain medical conditions such as inflammatory disorders, immune disorders, oncological conditions, and several infections. By analyzing the cellular composition of the extracted tissue, healthcare experts can gain detailed insights into the patient's condition. Despite its diagnostic importance, biopsy is an invasive technique which can cause pain, discomfort and may lead to severe complications, such as bleeding and infections. To mitigate these issues, advancements in medical technology have led to the development of less invasive techniques, such as virtual biopsy.
To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/virtual-biopsy-market/request-quote.html
Virtual biopsy is a non-invasive imaging technique that uses artificial intelligence (AI) to create a 3D image of tissue cells from medical scans. This technique is usually done by combining the medical images acquired via different imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound scans, with AI. These images are further used as reference to detect any anomaly in the sample tissue without any incisions or surgeries. This allows physicians to visualize and characterize any tissue safely, and to take informed and data-driven decisions for further treatment planning. Thus, these aforementioned advantages lead to significant growth of virtual biopsy market during the forecast period.
To request a sample copy / brochure of this report, please visit:
https://www.rootsanalysis.com/reports/virtual-biopsy-market/request-sample.html
Steps involved in performing virtual biopsy
1. Acquisition of Data: The first step involves the collection of high-quality annotated images, clinical, pathological, and molecular data from various imaging techniques.
2. Data Harmonization: After data collection, it undergoes data harmonization which involves several techniques, including filtering, normalization, and segmentation, to isolate specific areas of interest within the images.
3. Division of Data: The harmonized data is then segregated and categorized for three primary purposes, namely training, testing and validation of virtual biopsy technique.
4. Region of Interests (ROI) Segmentation: The preprocessed data undergoes ROI segmentation, where specific target areas within the images are characterized and marked. This step allows the differentiation of areas of interest from surrounding tissues.
5. Extraction and Selection of Image Features: In this step, various features from the segmented images are extracted for quantification. This includes feature extraction (FE) which focuses on quantifying these attributes and feature selection (FS) which identifies the most relevant features that contribute to the task at hand.
6. Validation of Model: The final step involves validating the developed model to ensure its accuracy and reliability. This is achieved by comparing the model's ability to characterize patient samples with the results obtained from conventional biopsy methods.
Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/virtual-biopsy-market.html
Future perspective of virtual biopsy
In recent years, the domain of virtual biopsy has witnessed several advancements. This progress is primarily attributed to an increased research and development aimed at creating more robust models for quantifying and analyzing virtual biopsy data. These improvements facilitate more efficient diagnosis and prognosis of diseases within the healthcare sector. In addition to model development and validation, there is a critical need for the collection of large datasets, comprehensive annotation and the expansion of storage capacities to accommodate high-quality, high-depth images. Such measures are essential for models to accurately reference datasets, enabling them to identify patterns and analyze the intricacies of cellular and subcellular compositions across various tissues. Researchers in this domain are also prioritizing the implementation of advanced image acquisition techniques to enhance the quality of image datasets, thereby revolutionizing virtual biopsy applications in healthcare. With growing interest from researchers and the rapid integration of imaging technology, the development of more robust databases for quantification will increase stakeholders reliability in this technique. These advancements are expected to introduce more sophisticated and effective virtual biopsy techniques to the market, transforming the healthcare sector.
Research objectives:
1. The Virtual Biopsy Market report studies the worldwide market consumption rate in terms of value and volume.
2. It identifies the various sub-segments of the market structure.
3. It proffers information regarding the leading global manufacturers in this industry, describing their market value & share, sales volume, competitive analysis, SWOT analysis, and development strategies adopted during the forecast timeline.
4. The report describes the key industry players, with respect to their individual growth trends, future prospects, and contribution to the global market, and explains the factors related to their market growth potential, drivers, opportunities, threats, and industry-specific challenges.
5. Furthermore, the report underpins the strategic developments occurring in the global market, such as expansions, mergers & acquisitions, agreements, as well as new product launches.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
Contact Details for Roots Analysis
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com/
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biopsy is defined as a procedure of removing or extracting tissue from the body through various methods, such as surgical, needle, laparoscopic techniques. here
News-ID: 4223621 • Views: …
More Releases from Roots Analysis
T-Cell Therapy Market Size to Hit USD 20.9 billion by 2035| Exclusive Report by …
Cancer is one of the leading causes of mortality across the world. As per the International Agency for Research on Cancer (IARC), by 2040, there are likely to be 27.5 million new cases and 16.3 million deaths related to cancer, annually. Although cancer therapeutics continue to be one of the most active areas, in terms of drug development, there is still a significant unmet need in this domain. In fact,…
Cancer Biologics Market: Unmet Need and Treatment Guidelines
Owing to the increasing mortality rates and growing need for novel modalities to treat oncological disorders, several researchers and industry stakeholders have shifted their focus on the development of safe and effective biologic therapies. Cancer biologics are the class of therapeutic agents, which primarily modulate immune responses or directly inhibits oncogenic pathways in malignancies. These therapies, such as monoclonal antibodies, specifically target tumor-activating genes, facilitate antibody-dependent cellular cytotoxicity and complement…
Peptide Synthesis: Supporting Next Generation Targeted Therapies
Peptides are specialized molecules composed of short chains of amino acids and are used primarily as the active ingredients in a new class of targeted therapeutics. Peptide synthesis is achieved through various advanced methodologies, including chemical processes like solid-phase (SPPS) and liquid-phase (LPPS), as well as hybrid and non-chemical approaches.
Peptides are being extensively used as therapeutics to treat various disorders, including metabolic diseases, oncological disorders, and hormonal imbalances due to…
Prefilled Syringes Market Size to Hit USD 4.97 billion by 2035| Exclusive Report …
Prefilled syringes: setting new standards for safe and efficient drug administration. With the increasing population, the incidence rates of various chronic diseases, such as diabetes, autoimmune disorders, cardiovascular disorders and oncological disorders, are witnessing an upward trend.
The global prefilled syringes market, valued at USD 3.02 billion in 2024, is project to reach USD 3.19 billion in 2025 and USD 4.97 billion by 2035, representing a CAGR of 4.5% during the…
More Releases for Biopsy
Liquid Biopsy Market - Unlocking Insights in Liquid: Transforming the Biopsy Lan …
Newark, New Castle, USA: The "Liquid Biopsy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Liquid Biopsy Market: https://www.growthplusreports.com/report/liquid-biopsy-market/8430
This latest report researches the industry structure, sales, revenue,…
Biopsy Devices Market Overview by Breast Biopsy, Lung Biopsy, Prostate Biopsy to …
Download Free PDF Sample Papers Now at Biopsy Devices Market https://www.reportsnreports.com/contacts/requestsample.aspx?name=1159148 .
Biopsy devices market report analyzes various types of biopsy devices in market and their adoption patterns. It aims at estimating market size and future growth potential of biopsy devices market for different segments such as product, guidance technique, application, end user, and region. Global biopsy devices market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East…
Biopsy Device Market to Increase to US$ 2,621 Mn by 2026 | Guidance System (Ster …
Key players focussing on strategic M&A for amplified market shares
Patients are increasingly preferring minimally invasive surgical procedures in order to avoid conventional surgical complications and side-effects, promoting sales of biopsy devices, leading to the growth of the biopsy devices globally. In addition to enabling the accurate diagnosis, a biopsy device assures minimal patient discomfort and trauma. This is identified to be a major factor impacting the popularity of biopsy, and…
Breast Biopsy Market Report 2018: Segmentation by Product (Vacuum Assisted Biops …
Global Breast Biopsy market research report provides company profile for Hologic Inc., Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.), C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule medical Devices LLC. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume,…
Biopsy Devices Market Report 2018: Segmentation by Product (Core Needle Biopsy, …
Global Biopsy Devices market research report provides company profile for C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth…
Bone Biopsy Market 2018 | Needle Biopsy | Open Biopsy | Bone Cancer | Bone Infec …
The Global Bone Biopsy Market is growing continuously and expected to grow at a CAGR of 5.7% from 2017 to 2023. Bone biopsy is performed to diagnose various bone disorders such as bone cancer, bone infection, osteoporosis and chronic kidney disease. Nowadays, biopsy procedure has received great importance in oncology as one of the promising methods in cancer diagnostics. The demand for needle biopsy is found to be increasing from…
